2013 White Paper on recent issues in bioanalysis: 'hybrid'--the best of LBA and LCMS.

The 2013 7th Workshop on Recent Issues in Bioanalysis was held in Long Beach, California, USA, where close to 500 professionals from pharmaceutical and biopharmaceutical companies, CROs and regulatory agencies convened to discuss current topics of interest in bioanalysis. These 'hot' topics, which covered both small and large molecules, were the starting point for fruitful exchanges of knowledge, and sharing of ideas among speakers, panelists and attendees. The discussions led to specific recommendations pertinent to bioanalytical science. Such as the previous editions, this 2013 White Paper addresses important bioanalytical issues and provides practical answers to the topics presented, discussed and agreed upon by the global bioanalytical community attending the 7th Workshop on Recent Issues in Bioanalysis.

Stacy Ho | Roger Hayes | Eric Woolf | Magnus Knutsson | Binodh DeSilva | Lauren Stevenson | An Song | Rafiqul Islam | Surendra Bansal | Brian Booth | Fabio Garofolo | Adrien Musuku | Lakshmi Amaravadi | Heather Myler | Theingi Thway | Boris Gorovits | Sam Haidar | Noriko Katori | Jan Welink | Judy Y Shih | Alvydas Mikulskis | Gary Schultz | Stephanie Fraser | Marian Kelley | Chad Ray | Mario Rocci | Suzanne Martinez | Isabelle Dumont | Catherine Dicaire | Sherri Dudal | Dominique Gouty | Surinder Kaur | Jean Lee | Steve Lowes | Mark Ma | Eric Ormsby | Laixin Wang | Lauren F. Stevenson | Christopher Evans | Laura Wright | Eric Fluhler | Jeff Duggan | Shefali R Patel | Jason Wakelin-Smith | Jian Wang | Emma Whale | Timothy Olah | Shefali Patel | Hanlan Liu | Margarete Brudny-Kloeppel | Bob Nicholson | Valerie Theobald | Vincenzo Pucci | Rand Jenkins | Judy Shih | Richard Houghton | Mark Arnold | Sam H. Haidar | Dawn Dufield | Ronald Shoup | Laurence Mayrand-Provencher | Mike Losauro | Craig Simon | João Tavares Neto | Raymond Xu | T. Olah | S. Fraser | M. Knutsson | H. Myler | E. Woolf | R. Hayes | J. Welink | S. Dudal | E. Fluhler | B. Gorovits | B. Booth | Alvydas Mikulskis | F. Garofolo | E. Ormsby | D. Dufield | Surendra Bansal | T. Thway | M. Ma | R. Islam | A. Musuku | Emma Whale | Marian Kelley | C. Evans | A. Song | N. Katori | Binodh S Desilva | Jeffrey X. Duggan | R. Shoup | S. Kaur | M. Rocci | M. Arnold | Laixin Wang | Jian Wang | L. Amaravadi | V. Theobald | D. Gouty | M. Brudny-Kloeppel | S. Lowes | G. Schultz | Rand G. Jenkins | Hanlan Liu | S. Ho | S. Martinez | Isabelle Dumont | Catherine Dicaire | João Tavares Neto | Craig Simon | B. Nicholson | R. Xu | Mike Losauro | Richard Houghton | Laurence Mayrand-Provencher | Jean W. Lee | Jason Wakelin-Smith | Laura Wright | Chad A. Ray | Vincenzo Pucci

[1]  D Rodbard,et al.  Kinetics of two-site immunoradiometric ('sandwich') assays-II. Studies on the nature of the 'high-dose hook effect'. , 1978, Immunochemistry.

[2]  Viswanath Devanarayan,et al.  Fit-for-Purpose Method Development and Validation for Successful Biomarker Measurement , 2006, Pharmaceutical Research.

[3]  D Rodbard,et al.  Kinetics of two-site immunoradiometric ('sandwich') assays-I. Mathematical models for simulation, optimization, and curve fitting. , 1978, Immunochemistry.

[4]  N. Spooner,et al.  The effect of hematocrit and punch location on assay bias during quantitative bioanalysis of dried blood spot samples. , 2011, Bioanalysis.

[5]  Xia Yin,et al.  2009 White Paper on recent issues in regulated bioanalysis from the 3rd Calibration and Validation Group Workshop. , 2010, Bioanalysis.

[6]  Binodh DeSilva,et al.  Recommendations for the Bioanalytical Method Validation of Ligand-Binding Assays to Support Pharmacokinetic Assessments of Macromolecules , 2003, Pharmaceutical Research.

[7]  Fabio Garofolo,et al.  The 2nd Calibration and Validation Group workshop on recent issues in good laboratory practice bioanalysis. , 2009, Bioanalysis.

[8]  Fabio Garofolo,et al.  Large-molecule quantification: sensitivity and selectivity head-to-head comparison of triple quadrupole with Q-TOF. , 2013, Bioanalysis.

[9]  Boris Gorovits,et al.  Bioanalysis of antibody–drug conjugates , 2013 .

[10]  Surinder Kaur,et al.  Bioanalysis of antibody-drug conjugates: American Association of Pharmaceutical Scientists Antibody-Drug Conjugate Working Group position paper. , 2013, Bioanalysis.

[11]  Stacy Ho,et al.  2011 White paper on recent issues in bioanalysis and regulatory findings from audits and inspections. , 2011, Bioanalysis.

[12]  Naidong Weng,et al.  Challenges in urine bioanalytical assays: overcoming nonspecific binding. , 2010, Bioanalysis.

[13]  Viswanath Devanarayan,et al.  Recommendations for the validation of cell-based assays used for the detection of neutralizing antibody immune responses elicited against biological therapeutics. , 2011, Journal of pharmaceutical and biomedical analysis.

[14]  Roger Hayes,et al.  Recommendations on: internal standard criteria, stability, incurred sample reanalysis and recent 483s by the Global CRO Council for Bioanalysis. , 2011, Bioanalysis.

[15]  Kevin Bateman,et al.  2 Bioanalytical report writing , 2022 .

[16]  Fabio Garofolo,et al.  Large molecule bioana lysis using Q-TOF without predigestion and its data processing , 2012 .

[17]  Fabio Garofolo,et al.  Conference report: the 3rd Global CRO Council for Bioanalysis at the International Reid Bioanalytical Forum. , 2011, Bioanalysis.

[18]  Boris Gorovits,et al.  Theoretical Considerations and Practical Approaches to Address the Effect of Anti-drug Antibody (ADA) on Quantification of Biotherapeutics in Circulation , 2013, The AAPS Journal.

[19]  Roger Hayes,et al.  Recommendations on biomarker bioanalytical method validation by GCC. , 2012, Bioanalysis.

[20]  Eric Woolf,et al.  2010 white paper on recent issues in regulated bioanalysis & global harmonization of bioanalytical guidance. , 2010, Bioanalysis.

[21]  Lee Goodwin,et al.  Bioanalytical approaches to analyzing peptides and proteins by LC--MS/MS. , 2011, Bioanalysis.

[22]  Marie Eriksson,et al.  Capillary microsampling of 25 µl blood for the determination of toxicokinetic parameters in regulatory studies in animals. , 2012, Bioanalysis.

[23]  Heather Myler,et al.  Bioanalytical Approaches to Quantify “Total” and “Free” Therapeutic Antibodies and Their Targets: Technical Challenges and PK/PD Applications Over the Course of Drug Development , 2011, The AAPS Journal.

[24]  Surinder Kaur,et al.  Bioanalytical assay strategies for the development of antibody-drug conjugate biotherapeutics. , 2013, Bioanalysis.

[25]  R A Hamilton,et al.  Determination of mean valproic acid serum level by assay of a single pooled sample , 1981, Clinical pharmacology and therapeutics.